1. Home
  2. SYPR vs XLO Comparison

SYPR vs XLO Comparison

Compare SYPR & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SYPR

Sypris Solutions Inc.

HOLD

Current Price

$1.70

Market Cap

47.4M

Sector

Industrials

ML Signal

HOLD

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$7.96

Market Cap

56.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SYPR
XLO
Founded
1997
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
56.9M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
SYPR
XLO
Price
$1.70
$7.96
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 24.0K
10.9K
Earning Date
11-11-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ $82,294,000.00
$43,766,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 589.88
52 Week Low
$1.67
$0.46
52 Week High
$4.74
$25.17

Technical Indicators

Market Signals
Indicator
SYPR
XLO
Relative Strength Index (RSI) 38.03 28.75
Support Level N/A $7.37
Resistance Level $2.10 $8.97
Average True Range (ATR) 0.13 0.43
MACD -0.02 -0.11
Stochastic Oscillator 4.26 5.59

Price Performance

Historical Comparison
SYPR
XLO

About SYPR Sypris Solutions Inc.

Sypris Solutions Inc provides products and engineering, design, and manufacturing services for a variety of critical infrastructure sectors, including energy, space, communications, defense, transport, chemical, and water. The company operates in two segments, Sypris Technologies and Sypris Electronics. Sypris Technologies segment includes the sale of forged, machined, welded and heat-treated steel components for heavy commercial vehicle and high-pressure energy pipeline applications, whereas the Sypris Electronics segment includes revenue from circuit card and box build manufacturing, high reliability manufacturing and systems assembly and integration, for aerospace and defense, communications and space applications. The majority of revenue is derived from the Sypris Electronics segment.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: